Singapore markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
150.00-0.57 (-0.38%)
At close: 04:03PM EDT
150.00 0.00 (0.00%)
After hours: 07:50PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
56,725,000
56,197,000
45,804,000
33,266,000
32,753,000
Cost of revenue
17,285,000
17,446,000
15,387,000
7,439,000
7,718,000
Gross profit
39,440,000
38,751,000
30,417,000
25,827,000
25,035,000
Operating expenses
Research development
6,914,000
7,084,000
6,557,000
6,407,000
10,329,000
Selling general and administrative
12,634,000
12,349,000
11,299,000
6,942,000
7,399,000
Total operating expenses
19,980,000
19,865,000
17,856,000
12,459,000
18,228,000
Operating income or loss
19,460,000
18,886,000
12,561,000
13,368,000
6,807,000
Interest expense
2,339,000
2,423,000
2,454,000
1,784,000
1,348,000
Total other income/expenses net
-3,108,000
-3,513,000
-6,883,000
-3,433,000
-466,000
Income before tax
14,051,000
12,989,000
3,398,000
8,426,000
5,197,000
Income tax expense
1,564,000
1,440,000
-1,224,000
544,000
-490,000
Income from continuing operations
12,487,000
11,549,000
4,622,000
7,882,000
5,687,000
Net income
12,479,000
11,542,000
4,616,000
7,882,000
5,687,000
Net income available to common shareholders
12,407,000
11,468,000
4,556,000
7,842,000
5,657,000
Basic EPS
-
-
2.62
5.33
3.85
Diluted EPS
-
-
2.62
5.28
3.66
Basic average shares
-
-
1,765,133
1,478,911
1,478,824
Diluted average shares
-
-
1,765,133
1,484,000
1,546,000
EBITDA
-
23,933,000
12,323,000
12,227,000
8,310,000